drug
as of 2026-07-0121 mg transdermal nicotine
at a glance
small molecule
Pre-approval / investigational in the US
Developed by National Institute on Drug Abuse (NIDA)
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
1
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
NCT00218218Phase 2Completed
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here